Nanobiotix S.A. American Depositary Shares

The global nanobiotechnology market is projected to grow from USD 172.81 billion in 2024 to USD 420.2 billion by 2034, driven by healthcare demand, R&D funding, and technological innovations in drug delivery and medical applications.

French biotechnology company Nanobiotix has experienced a 660% stock surge in 2025, driven by promising cancer-fighting drug development and strategic partnerships with Johnson & Johnson and Healthcare Royalty Partners.

U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Thursday. Shares of CarMax, Inc. (NYSE: KMX) fell sharply in today’s pre-market trading after the company reported lower-than-expected fourth-quarter earnings. CarMax posted quarterly earnings of 32 cents per share, missing market estimates of 49 cent...

Baillie Gifford’s 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. Click here for a detailed analysis.